Mitchell Steiner
About Mitchell Steiner
Mitchell Steiner - Chairman, President, and CEO
Mitchell Steiner currently holds the prominent positions of Chairman, President, and Chief Executive Officer. With a career spanning several decades, Steiner has co-founded and led various organizations including Aspen Park and GTx, Inc. His leadership roles have cemented his reputation in the medical and corporate sectors.
Mitchell Steiner Education and Medical Training
Mitchell Steiner holds a B.A. in Molecular Biology and Chemistry from Vanderbilt University and an M.D. from the University of Tennessee. He completed his surgical and urologic training at The Johns Hopkins Hospital and served as a postdoctoral research fellow in cell biology at Vanderbilt School of Medicine. Steiner's academic appointments include Assistant Professor of Urology, Cell Biology, and Pathology at Vanderbilt School of Medicine from 1993 to 1995.
Mitchell Steiner's Leadership at Aspen Park
From July 2014 to October 2016, Mitchell Steiner was the Chief Executive Officer, President, and Vice Chairman of the Board for Aspen Park. During his tenure, Steiner co-founded the company and played a critical role in its strategic direction and management.
Mitchell Steiner's Role at OPKO Health, Inc.
Between 2014 and 2016, Mitchell Steiner contributed to OPKO Health, Inc., first as a consultant and then as the President of Urology and a member of the senior management. His expertise in the medical field drove significant advancements within the company's urology segment.
Mitchell Steiner's Founding and Leadership of GTx, Inc.
Mitchell Steiner co-founded GTx, Inc., a men's health and oncology public company, where he served as Chief Executive Officer and Vice Chairman of the Board from 1997 to 2014. Under his leadership, GTx, Inc. specialized in developing therapies for cancer and other serious illnesses that predominantly affect men.
Mitchell Steiner's Academic Contributions at University of Tennessee
From 1995 to 2004, Mitchell Steiner held several key academic positions at the University of Tennessee, including Chairman and Professor of Urology, Director of Urologic Oncology and Research, and the Chair of Excellence in Urologic Oncology. His work contributed significantly to research and education in urologic oncology.